This is a translation of the Swedish press release published 2023-02-01
Neola Medical AB (publ) initiates market preparations before the launch of its medical device, Neola™ for continuous monitoring of the lungs of preterm born babies. The first action is a partnership with the international digital network for neonatologists, 99NICU. In “NEOvations”, a new webinar series focusing on new technology for neonatology, Neola Medical will present Neola™, its lung monitoring device. The Italian neonatologist MD Ph.D. Gianluca Lista is invited by Neola Medical as keynote speaker, to talk about how the care of preterm born babies can be improved with non-invasive lung monitoring.
Neola Medical AB (publ) today announces that the Company is initiating market preparation work before the launch of Neola™, Neonatal Lung Analyzer, which will take place after market approval by the FDA in the U.S. The work starts with a partnership with 99NICU, an international network of neonatologists, and participation in the new webinar series, NEOvations, focusing on innovative ideas for neonatal care the 14th of February.
“99NICU is a valuable platform for neonatologists to discuss and share experiences in neonatal intensive care and we look forward to presenting our product in this important forum. We believe it is important to highlight new opportunities and innovations in neonatal care and it is a great honor to have Dr. Gianluca Lista as keynote speaker for our webinar. I look forward to the presentation and the important topic of how we can improve the care of preterm born babies through non-invasive monitoring.”, says Tetiana Kovtiukh Clinical Manager at Neola Medical.
Read the entire translation of the Swedish press release here: Press communication
Read the entire press release (in Swedish) here: Press release
